Physician profile
James E Mckiernan
NPI 1336126515
$2,479.13
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,183 · 2020: $285 · 2021: $11.49.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $818.75 | 2019-2020 | |
| Ucb, INC. | $395.61 | 2019-2020 | |
| Amgen INC. | $221.76 | 2019-2021 | |
| Allergan, INC. | $154.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $144.04 | 2019 | |
| Akcea Therapeutics, INC. | $121.10 | 2019 | |
| Eisai INC. | $86.47 | 2019 | |
| Alexion Pharmaceuticals, INC. | $72.96 | 2019 | |
| Acorda Therapeutics, INC | $58.38 | 2019-2020 | |
| Promius Pharma LLC | $57.81 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $57.59 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $41.61 | 2019-2020 | |
| Grifols USA, LLC | $40.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $36.20 | 2019 | |
| Upsher-Smith Laboratories LLC | $34.26 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.63 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $28.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.50 | 2019 | |
| Zyla Life Sciences, INC. | $13.73 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.68 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.66 | 2019 | |
| Currax Pharmaceuticals LLC | $11.74 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mckiernan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.